These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32890919)

  • 1. Successful engagement in buprenorphine treatment among hospitalized patients with opioid use disorder and trauma.
    Bhatraju EP; Ludwig-Barron N; Takagi-Stewart J; Sandhu HK; Klein JW; Tsui JI
    Drug Alcohol Depend; 2020 Oct; 215():108253. PubMed ID: 32890919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Hospital Adoption of an Emergency Department Treatment Pathway for Opioid Use Disorder and Patient Initiation of Buprenorphine After Discharge.
    Solomon KT; O'Connor J; Gibbons JB; Kilaru AS; Feder KA; Xue L; Saloner B; Stuart EA; Cole ES; Hulsey E; Meisel Z; Patel E; Donohue JM
    JAMA Health Forum; 2023 Mar; 4(3):e230245. PubMed ID: 36961457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid Use Disorder Treatment Initiation and Continuation: a Qualitative Study of Patients Who Received Addiction Consultation and Hospital-Based Providers.
    Calcaterra SL; Lockhart S; Callister C; Hoover K; Binswanger IA
    J Gen Intern Med; 2022 Aug; 37(11):2786-2794. PubMed ID: 34981359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and treatment of opioid use disorders among primary care patients in six health systems.
    Lapham G; Boudreau DM; Johnson EA; Bobb JF; Matthews AG; McCormack J; Liu D; Samet JH; Saxon AJ; Campbell CI; Glass JE; Rossom RC; Murphy MT; Binswanger IA; Yarborough BJH; Bradley KA;
    Drug Alcohol Depend; 2020 Feb; 207():107732. PubMed ID: 31835068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buprenorphine Induction in Trauma Patients With Opioid Use Disorder - A Single Center Experience?
    Roth E; Bingaman A; Stern S; McKeever R; D'Orazio J; Schlosser SP; Cheng K; Zhao H; Anderson JH
    J Surg Res; 2024 Sep; 301():686-695. PubMed ID: 39163801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose buprenorphine initiation and treatment continuation among hospitalized patients with opioid dependence: A retrospective cohort study.
    Hayes BT; Li P; Nienaltow T; Torres-Lockhart K; Khalid L; Fox AD
    J Subst Use Addict Treat; 2024 Mar; 158():209261. PubMed ID: 38103838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention.
    D'Onofrio G; Chawarski MC; O'Connor PG; Pantalon MV; Busch SH; Owens PH; Hawk K; Bernstein SL; Fiellin DA
    J Gen Intern Med; 2017 Jun; 32(6):660-666. PubMed ID: 28194688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial.
    Liebschutz JM; Crooks D; Herman D; Anderson B; Tsui J; Meshesha LZ; Dossabhoy S; Stein M
    JAMA Intern Med; 2014 Aug; 174(8):1369-76. PubMed ID: 25090173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trauma treatment for veterans in buprenorphine maintenance treatment for opioid use disorder.
    Meshberg-Cohen S; Black AC; DeViva JC; Petrakis IL; Rosen MI
    Addict Behav; 2019 Feb; 89():29-34. PubMed ID: 30243036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of emergency department-initiated treatment for opioid dependence.
    Busch SH; Fiellin DA; Chawarski MC; Owens PH; Pantalon MV; Hawk K; Bernstein SL; O'Connor PG; D'Onofrio G
    Addiction; 2017 Nov; 112(11):2002-2010. PubMed ID: 28815789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initiating buprenorphine treatment for hospitalized patients with opioid dependence: A case series.
    Suzuki J; DeVido J; Kalra I; Mittal L; Shah S; Zinser J; Weiss RD
    Am J Addict; 2015 Jan; 24(1):10-4. PubMed ID: 25823630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers and Facilitators to Clinician Readiness to Provide Emergency Department-Initiated Buprenorphine.
    Hawk KF; D'Onofrio G; Chawarski MC; O'Connor PG; Cowan E; Lyons MS; Richardson L; Rothman RE; Whiteside LK; Owens PH; Martel SH; Coupet E; Pantalon M; Curry L; Fiellin DA; Edelman EJ
    JAMA Netw Open; 2020 May; 3(5):e204561. PubMed ID: 32391893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers to initiate buprenorphine and methadone for opioid use disorder treatment with postdischarge treatment linkage.
    Calcaterra SL; Lockhart S; Natvig C; Mikulich S
    J Hosp Med; 2023 Oct; 18(10):896-907. PubMed ID: 37608527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of an opioid use disorder consult service on hospitalized trauma patients with opioid use disorder.
    Muller M; Weyer G; Zakrison T; Ari M
    J Trauma Acute Care Surg; 2023 Aug; 95(2):226-233. PubMed ID: 36914601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiating buprenorphine treatment for opioid use disorder during short-term in-patient 'detoxification': a randomized clinical trial.
    Stein M; Herman D; Conti M; Anderson B; Bailey G
    Addiction; 2020 Jan; 115(1):82-94. PubMed ID: 31430414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Pregnancy Recovery Center: A women-centered treatment program for pregnant and postpartum women with opioid use disorder.
    Krans EE; Bobby S; England M; Gedekoh RH; Chang JC; Maguire B; Genday P; English DH
    Addict Behav; 2018 Nov; 86():124-129. PubMed ID: 29884421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-overdose acute care hospitalizations for opioid use disorder among commercially-insured adults: a retrospective cohort study.
    Raman SR; Ford CB; Hammill BG; Clark AG; Clifton DC; Jackson GL
    Addict Sci Clin Pract; 2023 Jul; 18(1):42. PubMed ID: 37434260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Substance Use Treatment and Recovery Team (START) study: protocol for a multi-site randomized controlled trial evaluating an intervention to improve initiation of medication and linkage to post-discharge care for hospitalized patients with opioid use disorder.
    Ober AJ; Murray-Krezan C; Page K; Friedmann PD; Chan Osilla K; Ryzewicz S; Huerta S; Mazer MW; Leamon I; Messineo G; Watkins KE; Nuckols T; Danovitch I
    Addict Sci Clin Pract; 2022 Jul; 17(1):39. PubMed ID: 35902888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19: A catalyst for change in telehealth service delivery for opioid use disorder management.
    Mehtani NJ; Ristau JT; Snyder H; Surlyn C; Eveland J; Smith-Bernardin S; Knight KR
    Subst Abus; 2021; 42(2):205-212. PubMed ID: 33684331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming challenges in acute care hospitalizations for patients with opioid use disorder.
    Kerins A; Ito S; Ari M; Murray JP; Weyer G
    J Am Pharm Assoc (2003); 2023; 63(1):204-211.e2. PubMed ID: 36115762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.